Target intelligence / Profile preview

Wound environment modulation

Molecular classification
Other
01

Overview

Wound environment modulation is a therapeutic strategy focused on optimizing the biochemical and cellular conditions within a wound bed to facilitate natural healing processes (StatPearls, 2023). Rather than targeting a single molecule, this approach addresses a complex milieu consisting of the extracellular matrix, various cell types, and signaling molecules such as cytokines and growth factors (Journal of Wound Care, 2019). Chronic wounds, including diabetic and pressure ulcers, are often stalled in a pro-inflammatory phase characterized by high levels of matrix metalloproteinases (MMPs) and the presence of bacterial biofilms [PMID: 25488106]. Interventions aimed at modulating this environment include enzymatic debridement, moisture balance control, and the delivery of exogenous factors like Platelet-Derived Growth Factor (PDGF) [FDA: Regranex Label]. By restoring a favorable microenvironment, these therapies aim to transition the wound into the proliferative and remodeling phases of repair (NIH, 2022). Effective modulation is critical for managing non-healing wounds and promoting successful re-epithelialization and tissue regeneration.

Other names
Wound bed preparationWound microenvironment modulationTissue repair regulationWound bed modulation
02

Mechanism of action

Modulation of the wound microenvironment involves the restoration of biochemical balance by regulating moisture, reducing bacterial bioburden, and normalizing levels of proteases and growth factors to transition the wound from a chronic inflammatory state to a proliferative phase [PMID: 25488106].

03

Biological functions

Wound healingTissue regenerationInflammationCell proliferationAngiogenesis
04

Disease associations

Chronic woundDiabetic foot ulcerPressure ulcerVenous leg ulcerBurn injury
05

Safety considerations

Localized skin irritationHypersensitivity reactionsRisk of systemic absorption of antimicrobial agentsPotential for hypertrophic scarring if over-stimulated
06

Interacting drugs

Becaplermin

4 more in the full profile.

07

Biomarkers

Matrix metalloproteinase-9 (MMP-9)Wound fluid pHExudate volumeBacterial load/Biofilm presenceC-reactive protein (CRP)

Beyond the preview

Go deeper on Wound environment modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wound environment modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call